enVVeno Medical (NVNO) Interest & Investment Income (2021 - 2026)
enVVeno Medical's (NVNO) quarterly Interest & Investment Income came in at $22000.0 in Q1 2026, down 89.95% year-on-year from $219000.0 in Q1 2025, and down 78.64% quarter-over-quarter from $103000.0 in Q4 2025.
enVVeno Medical (NVNO) Interest & Investment Income (2021 - 2026) Analysis & Trends
enVVeno Medical's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $22000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 89.95% year-over-year to $22000.0 in Q1 2026; TTM through Mar 2026 was $495000.0, a 9.84% decrease from a year earlier, with the FY2025 full-year figure at $692000.0, up 77.89% from the prior year.
- Interest & Investment Income slipped to $22000.0 in Q1 2026 per NVNO's latest filing, from $103000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $219000.0 in Q1 2025 and bottomed at $5000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $59000.0 (2024), against an average of $84941.2.
- Across the five-year window, Interest & Investment Income jumped 1400.0% in 2022 and plunged 89.95% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $44000.0 in 2022, then increased by 18.18% to $52000.0 in 2023, then surged by 213.46% to $163000.0 in 2024, then sank by 36.81% to $103000.0 in 2025, then sank by 78.64% to $22000.0 in 2026.
- Per Business Quant, the three latest NVNO Interest & Investment Income figures stand at $22000.0 (Q1 2026), $103000.0 (Q4 2025), and $175000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | enVVeno Medical | 6.85 Mn | 6.85 Mn | - | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Sep 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 219,000.00 |
| Dec 31, 2024 | 163,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 73,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 75,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 3,000.00 |